Navigation Links
You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes'

MINNEAPOLIS, Jan. 5 /PRNewswire/ -- In their latest book, You: Being Beautiful - The Owner's Manual to Inner and Outer Beauty (Free Press, 2008), co-authors Mehmet Oz, MD and Michael Roizen, MD refer to ribose as one of the decade's "real nutritional heroes" that can "turbo-charge" those who need an energy boost. Ribose is a naturally occurring 5-carbon sugar the body uses to stimulate the production of adenosine triphosphate (ATP) -- an essential energy compound.

Although ribose is produced by the body, this energy molecule cannot be replenished fast enough during certain times of demanding exercise, stress, or as a result of many chronic diseases. When added to foods and dietary supplements, D-Ribose enhances the body's natural process of energy synthesis. It reduces the loss of energy during stress, and accelerates energy and tissue recovery and the management of free radicals.

According to Jacob Teitelbaum, MD, Medical Director of the national Fibromyalgia and Fatigue Centers, Inc., and best-selling author of From Fatigued to Fantastic! (Penguin Group), we are in the midst of a human energy crisis. "We're witnessing an emerging worldwide exhaustion epidemic," said Teitelbaum. "The increased stress of modern life combined with poor sleep and nutrition is being reflected not only in the high levels of fatigue but in the accompanying epidemic of pain currently experienced by one in four Americans along with heart disease, the number one killer in the United States."

Dr. Teitelbaum's research published in the Journal of Alternative and Complementary Medicine (12:9, 2006), found a full two-thirds of his patients reported improvement of their symptoms in the first 12 days following a course of Corvalen(R) D-Ribose treatment. The average improvement in energy was 45 percent and quality of life improved an average of 30 percent. Patients reported less muscle soreness and stiffness, better ability to overcome fatigue, as well as simply feeling better. "Supplemental Corvalen(R) is part of a clinically proven program we've developed that is helping millions of people overcome the debilitating effects of Chronic Fatigue Syndrome and fibromyalgia as well as a general malaise of exhaustion," said Teitelbaum. Corvalen(R) is also used by physicians to treat congestive heart failure and to prepare patients for off-pump bypass surgery(1).

"Bioenergy D-Ribose(TM) also has sweeping applications for healthy people who need more energy every day," said Raj Khankari, Ph.D., CEO of Bioenergy, Inc. "It is already widely used as an effective training and recovery tool by high-performance athletes. We've only scratched the surface on the wide-ranging health and training benefits of this nutritional powerhouse."

Bioenergy, Inc. -- The Ribose Company(TM) -- (, recently achieved GRAS (generally recognized as safe) status for D-Ribose from the U.S. Food and Drug Administration. The privately held, Minneapolis-based life sciences company has amassed a large body of scientific literature on the uses of ribose for people across all age and health categories. It has more than 40,000 customers for its proprietary Corvalen(R) products alone, and millions worldwide use Bioenergy D-Ribose(TM) in other functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water). Currently, Bioenergy D-Ribose(TM) is included as an ingredient in approximately 100 products. The company's core technology lies in the development and commercialization of products based on the physiological benefits of D-Ribose for health and wellness.

    (1) D. Perkowski, MD, S. Wagner, RN, A. Marcus, MD, J. St. Cyr, MD, Ph.D.,
        Saddleback Hospital, Orange Co., CA, "D-Ribose Improves Cardiac
        Indices in Patients Undergoing "Off-Pump" Coronary Arterial
        Revascularization," presented at Academic Surgical Congress, February

SOURCE Bioenergy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. A Scientist Dechipers the Code to Beautiful, Healthy Skin in The New Science of Perfect Skin
2. With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
3. PNAS paper and its authors honored for scientific excellence
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
8. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
9. Pharmasset Appoints Michael Rogers as Chief Development Officer
10. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
11. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
Post Your Comments:
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... HART ), a biotechnology company developing bioengineered organ implants ... McGorry will present at the LD Micro "Main ... 2:30 p.m. PT. The presentation will be webcast live ... Management will also be available at the conference for ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
Breaking Biology Technology:
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):